Pharmacology and Pharmaceutical Sciences articles for Japan

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 58

Article ‘Count’ for Pharmacology and Pharmaceutical Sciences.

Journal Count Share
2 0.22
Self-Driven, Stretchable Drug Delivery Electronics for Acne Treatment 0.14
Cancer Cell Membrane-Coated Homodimer Prodrug Nanoassemblies to Simultaneously Deliver Prodrugs and Immune Adjuvants for Combined Chemo-Immunotherapy 0.08
7 6.57
Development of Magnetic Microbeads Equipped with Temperature-Responsive Artificial Antibodies for Efficient Anticancer Drug Administration 0.80
Stereochemical and Structural Characterization of Methionine Oxidation in the IgG1 Fc Region by Integrated NMR and LC-MS Analysis 1.00
Development of a Sensitive Lateral Flow Immunoassay Using Recombinant Rabbit Single-Chain Variable Fragments Fused to a Nitrocellulose-Binding Protein 0.86
Integrative Real-Time NMR and X-ray Crystallography Reveal Prostaglandin D2 Metabolism 1.00
Quantifying Cell Membrane Permeability of Small to Mid-Size Drugs Using Quick Osmotic Cytoplasm Extraction 0.92
The Structural Fingerprint of Therapeutic Monoclonal Antibodies Determined Using a Combination of Near-UV Circular Dichroism and Statistical Approach for Comparative Analysis 1.00
Fate of Stressed Oligoclonal Antibodies Tracked by Fluorescence Cross-Correlation Spectroscopy: IgG Aggregation Proceeds across the Species Barrier 1.00
3 3.00
Second‐Generation Crystalline Sponges Enabling Consistent Structure Analysis Under Standardized Conditions for Diverse Molecules 1.00
In Cellulo Multistep Synthesis of Antitumor Zwitterionic Heterocycles Triggered by Cancer-Specific Acrolein 1.00
Desolvation‐Induced Network Reformation and Cracking in the Single Crystals of Hydrogen‐Bonded Frameworks Composed of Tetraazaanthraquinone and Anthraquinone Derivatives 1.00
1 0.14
Glucagon-Like Peptide-1 Receptor Agonists and Incidence of Dementia Among Older Adults With Type 2 Diabetes : A Target Trial Emulation. 0.14
1 0.06
Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH study 0.06
2 1.07
Garlic-derived metabolite activates LKB1, promotes adipose eNAMPT secretion, and improves age-related muscle function via hypothalamic signaling 0.95
Glucose-dependent insulinotropic polypeptide receptor signaling in oligodendrocytes increases the weight-loss action of GLP-1R agonism 0.12
4 3.11
Crystal engineering enables room-temperature triplet-DNP in cocrystals 1.00
Ionic liquid-based transdermal drug delivery systems for biopharmaceuticals 0.67
Beyond serendipity: uncovering novel ratiometric urea·24DHBA cocrystals through mechanochemistry and MicroED 0.44
Nanomorphology tuning in doxorubicin-loaded liposomes ivia/i cooling-induced doxorubicin-crystallization and membrane phase transition 1.00
1 0.92
Fully dissolved glucose-responsive insulin delivery system based on a self-immolative insulin prodrug and glucose oxidase 0.92
1 0.02
Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood 0.02
1 0.02
Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP). 0.02
1 1.00
Maternal blood metal levels during pregnancy and body mass index z-score, overweight, and obesity among children: Findings of the Japan Environment and Children's Study 1.00
1 1.00
Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison 1.00
4 3.64
The stress-activated kinase p38 mediates non-canonical activation of Src and tyrosine phosphorylation of the adapter protein TAB1 0.94
Protein tyrosine kinase Src suppresses hepatitis C virus particle release through regulation of Ndrg1 0.70
A new amidohydrolase and β-oxidation–like pathway for piperine catabolism in soil actinomycetes 1.00
Conversion of an agonistic anti-TNFR2 biparatopic antibody into an antagonist by insertion of peptide linkers into the hinge region 1.00
1 0.06
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations. 0.06
1 0.44
Development and validation of prognostic models using novel inflammatory markers for drug reactions with eosinophilia and systemic symptoms: An international multicenter cohort study 0.44
5 3.25
Unlabeled NMR Approach with Site-Specific Methyl Assignments for Structural Evaluation of the IgG1 Fc Region 1.00
Chem–Bio Hybrid Synthesis Enables Reengineering of Natural Product-Based Methionine Aminopeptidase 2 Inhibitors for Treating Amebiasis 1.00
Discovery of Supra-Bivalent GSK3β Inhibitory Peptides Containing an ATP-Mimetic Amino Acid 0.93
Vitrification and Cold Crystallization of a One-Dimensional Perovskite-like Compound Enabled by Reorganizable Coordination Bonds and a Configurationally Restricted Cation 0.18
Elucidating the Biosynthetic Pathway and Mechanisms of Retrochalcones 0.14
2 1.04
Quantifying Poly(lactide-co-glycolide) Residual Dimer-Alternating Structure and Block-Length Distribution Using Controlled Chemical Degradation and Reverse-Phase Liquid Chromatography–Mass Spectrometry Analysis 0.04
Osmotic Pressure-Based Quantification of Network Inhomogeneity in Gels via Free Radical Polymerization 1.00
6 3.36
Hidden structural states of proteins revealed by conformer selection 0.20
Reliable repurposing of the antibody interactome inside the cell 0.13
Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool 0.07
Single-molecule characterization of opioid receptor heterodimers reveals soluble µ-δ dimer blocker peptide alleviates morphine tolerance 0.95
Single-molecule methods for characterizing receptor dimers reveal metastable opioid receptor homodimers that induce functional modulation 1.00
Structural and dynamic insights into the biased signaling mechanism of the human kappa opioid receptor 1.00
1 0.04
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals 0.04
1 0.15
Runx1 transcription factor modulates opioid analgesia and withdrawal in humans and rodents 0.15
1 0.67
Biosynthesis of Circumdatins Employs an Anthranilate Tailoring Pathway for NRPS Substrate Supplies 0.67
1 1.00
Isoflurane activates the type 1 ryanodine receptor to induce anesthesia in mice 1.00
1 0.13
The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study 0.13
1 0.98
Discovery and development of an oral analgesic targeting the α2B adrenoceptor 0.98
2 0.33
Mechanistic insights into the therapeutic properties of delta opioid receptor 0.08
AI-assisted protein design to rapidly convert antibody sequences to intrabodies targeting diverse peptides and histone modifications 0.25
1 0.40
Enantiomer-Specific Nucleation Phase Selection under Nonequilibrium Optical Trapping 0.40
4 0.28
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial 0.13
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials 0.06
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial 0.05
The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysis 0.05
1 0.07
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide 0.07

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.